Alerts
Modified Hours for Martin Luther King Jr. Day

In recognition of the upcoming Martin Luther King Jr. Day holiday, some of The University of Kansas Cancer Center’s offices will have modified hours on Monday, January 20, 2025.

Skip Navigation

A Phase II Efficacy and Safety Trial of ADU-S100 and Pembrolizumab in Adults with Head and Neck Cancer

Brief Summary

Type:
Head and Neck Cancers

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03937141

Study #:
STUDY00144482

Start Date:
Jan 01, 0001

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03937141

View Complete Trial Details & Eligibility at ClinicalTrials.gov